Navigation Links
Long-Term European Data Released for SUPERA® Stent from IDEV Technologies
Date:1/26/2011

LEIPZIG, Germany, Jan. 26, 2011 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks patients treated with the SUPERA wire interwoven nitinol stent.  The SUPERA stent is CE marked for biliary and peripheral vascular use in Europe.  In the United States, the SUPERA stent is currently being studied in an ongoing FDA approved IDE trial for treatment of peripheral arterial disease of the superficial femoral artery (SFA).

The single-center registry includes data from 107 patients treated for peripheral arterial disease of the SFA.  Within the study population, about a third of the patients had occlusions, 17 percent were categorized as Rutherford 4 or 5, and another 82 percent were Rutherford 3.  Additionally, half the treated lesions required placement of the SUPERA stent in the distal third of the SFA.  These highly diseased patients, with severely calcified lesions, had an average treated lesion length of approximately 11 centimeters, nearly double that in other stent trials.  

Results were presented by Sven Braunlich, MD of the Department of Angiology at Park Hospital and Heart Center, Leipzig, Germany during the 2011 Leipzig Interventional Course (LINC).  Key data points include a primary patency rate of 76 percent by duplex ultrasonography at two years with no stent fractures.  The 12-month patency rate was 85 percent, and the 18-month patency rate was also 76 percent, showing stable patency from 18 to 24 months.

Dr. Braunlich remarked, "The SUPERA stent has been shown in independent testing to be extremely crush and fracture resistant compared to standard nitinol stents.  Combined with the flexibility of the interwoven design, it is very well suited for use in the challenging SFA. X-ray
'/>"/>

SOURCE IDEV Technologies, Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
2. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR Devices
3. Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America
4. Luminex and One Lambda Renew Long-Term Strategic Partnership
5. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices
6. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
7. Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study
8. Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes
9. National University Hospital Singapore Operates on Asias 1st TRAM Flap Patient Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
10. MPO Symposium Panel Discussion to Address Open-Book Pricing and Its Effect on Long-Term Performance
11. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... 28, 2015  IP Shakti, LLC, today announced that it ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... new corporate identity signifies our transformation into a company focused ... platform for patent claim validity." ... proprietary AIA Shield™ platform, the Company commenced a corporate re-branding ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Latanoprost Market Investigation Report 2015-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... Diversifies Revenue Streams and Boosts Scale in Existing Generics ... Expected to be Immediately Accretive to Adjusted Diluted Earnings per ... Company Reiterates Full-Year 2010 Financial Guidance ... today that it has entered into a definitive agreement to ...
... (Nasdaq: DCTH ) announced today that management will ... Tuesday, October 5, 2010 at 8:45 a.m. ET in New ... an overview of the Company,s business strategy and recent corporate ... only. Delcath will offer a live audio webcast of its ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 2Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 3Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 4Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 5Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 6Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 7Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 8Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion 9Delcath to Present at the William Blair Emerging Growth Stock Conference 2
(Date:8/30/2015)... ... ... Scientists in France say asbestos exposure may put workers at higher risk for ... posted an article on the new research. Click here to read it now. ... French asbestos plant workers from 1978 to 2009. In addition to mesothelioma, the workers ...
(Date:8/30/2015)... , ... August 30, 2015 , ... ... has been promoted from Administrative assistant to Executive Assistant to CEO Mitch Gould ... a proven professional, focused on your goals. Kathleen graduated from Florida State ...
(Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, ... (Meso Foundation) will present an educational program titled “Asbestos and Your Health.” , ... 9:30 PM (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park ...
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now available on ... was required to qualify for free standard shipping,” said Jennifer Ramirez, the public relations ... of the item’s selling price.” , With competitive pricing in the e-commerce market for ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES IN ... announced that it will be devoting an entire short segment to the subject of ... around the globe on a daily basis, but recent advancements in medical science may ...
Breaking Medicine News(10 mins):Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2
... Health Foundation,s Annual Salute to Service Award , ... second consecutive year, Jim Kerwin of Oxford Communications ( ... announce that Oxford Communications will be the primary sponsor ... Award Luncheon on June 17th and Celebrity Golf Tournament ...
... Agency hopes to better explain its decisions to regain lost ... Food and Drug Administration, an agency long criticized for not ... it has created a task force to study how to ... to try and figure out how to make FDA and ...
... LAUDERDALE, Fla., June 2 LifeSync Corporation, the ... announced that Florida Hospital in Orlando has completed ... its Cardiovascular Institute for patients undergoing cardiovascular surgery. ... in the Florida Hospital System, houses the Florida ...
... This ... health care advocacy but it does little to help the public, says Erika Schwartz, MD ... (PRWEB) June 2, 2009 -- This week,s ... care advocacy but it does little to help the public, says Erika Schwartz, MD in her ...
... PEMBROKE, Bermuda, June 2 Darwin ... Company,Holdings, Ltd (NYSE: AWH ), today ... Manager, will be participating in a,panel at the American ... 3, 2009. The roundtable is titled "Market, Claims,and Healthcare ...
... , MILLERSVILLE, Md., June 2 Travel Advantage Network ... spring morning to support the National Alliance for Research ... kilometers of it. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090602/DC26325 ) ... support the charity by completing a 2.5K sponsored walk at ...
Cached Medicine News:Health News:Jim Kerwin Announces Oxford Communications To Be the Title Sponsor of Bermuda Health Foundation Salute for the Second Year 2Health News:FDA to Study Ways to Be More Open With Public 2Health News:FDA to Study Ways to Be More Open With Public 3Health News:Florida Hospital Cardiovascular Institute Completes House-Wide Implementation of the LifeSync(R) Wireless ECG System 2Health News:Florida Hospital Cardiovascular Institute Completes House-Wide Implementation of the LifeSync(R) Wireless ECG System 3Health News:Dr Erika Says Newsweek's Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 2Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 2Health News:Darwin's Kim Lloyd to Speak on Panel at American Hospital Association Solutions Roundtable, June 3, 2009 3Health News:A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 2
... for Western Blot analysis ... Western Blot Analyzer for many applications including ... presence of infectious diseases such as viruses ... accurate screening of allergies and other application ...
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... Store 200 to 350 Liters of ... Storage and Distribution of Purified Water,Millipores compact ... to store 200 to 350 liters of ... systems, and to maintain consistent purity of ...
... Liters of pure water, Complete, Compact Systems ... Water,Millipores compact S.D.S. Storage and Distribution Systems ... liters of purified water produced by Elix ... purity of stored water, provide effective protection ...
Medicine Products: